Key Financial Data Of Reporting Company

KOBAYASHI PHARMACEUTICAL CO.,LTD. - Filing #7336869

Concept 2024-01-01 to
2024-03-31
As at
2024-03-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-03-31
As at
2023-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
36,485,000,000 JPY
173,455,000,000 JPY
33,467,000,000 JPY
Ordinary profit (loss)
5,461,000,000 JPY
27,330,000,000 JPY
5,168,000,000 JPY
Net assets
204,966,000,000 JPY
204,816,000,000 JPY
198,809,000,000 JPY
Total assets
261,253,000,000 JPY
267,473,000,000 JPY
252,903,000,000 JPY
Basic earnings (loss) per share
13.13
268.16
47.43
Diluted earnings per share
Equity-to-asset ratio
0.783 xbrli:pure
0.764 xbrli:pure
0.785 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.